Overview
Xiufeng Hu practices in Zhengzhou, China. Their top areas of expertise are Cerebral Hypoxia, Lung Adenocarcinoma, Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC).
Their clinical research consists of co-authoring 14 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Frequently Asked Questions about Xiufeng Hu
Is Xiufeng Hu a top-rated expert for Cerebral Hypoxia?
MediFind is an objective health platform that identifies experts based on real-world data. Xiufeng Hu is classified as an Experienced expert for Cerebral Hypoxia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Xiufeng Hu participate in research or clinical trials?
Yes. Xiufeng Hu has published 14 articles and abstracts on conditions like Cerebral Hypoxia. You can view a list of Xiufeng Hu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cerebral HypoxiaHu isExperienced. Learn about Cerebral Hypoxia.
- Lung AdenocarcinomaHu isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerHu isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)